Could whole-body maximum standardized uptake value and metabolic tumor volume by FDG PET/CT further stratify the prognosis of locally advanced breast cancer patients?
Laura Evangelista(Istituto Oncologico Veneto), Giorgio Saladini(Society of Nuclear Medicine and Molecular Imaging), Anna Rita Cervino(Istituto Oncologico Veneto), Fernando A. Bozza(D’Or Institute for Research and Education), Tania Saibene(Istituti di Ricovero e Cura a Carattere Scientifico), Silvia Michieletto(Istituto Oncologico Veneto), Cristina Ghiotto(Istituto Oncologico Veneto)
Journal of Nuclear Medicine
May 1, 2015
Cited by 0
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492